搜索筛选:
搜索耗时0.0848秒,为你在为你在102,285,761篇论文里面共找到 3 篇相符的论文内容
发布年度:
[期刊论文] 作者：Elizabeth A.Kuczynski,Robert S,
来源：癌症：英文版 年份：2016
The reason why tumors generally have a modest or transient response to antiangiogenic therapy is not well understood. This poses a major challenge for sorafenib...
[期刊论文] 作者：Elizabeth A.Kuczynski,Robert S.Kerbel,,
来源：Chinese Journal of Cancer 年份：2016
The reason why tumors generally have a modest or transient response to antiangiogenic therapy is not well understood. This poses a major challenge for sorafenib...
[期刊论文] 作者：Elizabeth A.Kuczynski,Robert S.Kerbel,,
来源：Chinese Journal of Cancer 年份：2016
Advanced hepatocellular carcinoma(HCC)is difficult to treat Sorafenib is a selective inhibitor of vascular endothelial growth factor receptor 2(VEGFR2).HCCs are...
相关搜索：
